Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

COVID pill S-217622 shows rapid clearance of virus: Shionogi

Ruchika Sharma25 April 2022 10:00 AM IST

The company has global aspirations for the antiviral pill, which is now being evaluated by Japanese regulators.

Bayer appoints Tara Frenkl as new head of oncology development at oncology strategic business unit

Ruchika Sharma24 April 2022 11:30 AM IST

Berlin: Bayer has announced Tara Frenkl, MD, MPH as the new Head of Oncology Development at its Oncology Strategic Business Unit, effective April 25,...

Brinton Pharma to invest over Rs 3 crore to expand global RnD center in UK

Ruchika Sharma24 April 2022 11:00 AM IST

The investment helps the company to engage in a thriving life sciences ecosystem, supporting their global ambitions to build next generation...

Mansukh Mandaviya calls India as World largest pharmacy, vaccine manufacturing country

Ruchika Sharma24 April 2022 10:30 AM IST

Mandaviya further said that the Indian vaccines are more affordable as compared to other countries and many countries are showing interest in our...

GSK application to expand use of Nucala for COPD accepted for review by EMA

GSK- CureVac experimental COVID variant vaccine effective in mice study

Ruchika Sharma24 April 2022 9:15 AM IST

Frankfurt: CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly...

Bayer launches campaign 'Preserve The Uterus' to stall untimely hysterectomies in India

Ruchika Sharma24 April 2022 9:00 AM IST

Hysterectomy refers to an operation to remove a woman's uterus.

Pfizer recalls some lots of BP drug Accupril over presence of nitrosamine

Ruchika Sharma23 April 2022 4:10 PM IST

New York: Pfizer has announced the voluntary recall of five lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient...

DCGI panel asks Bharat Biotech to provide additional data on Covaxin for 2-12 years old

Ruchika Sharma23 April 2022 2:49 PM IST

No recommendations have been made as of now, sources told ANI.

Serum Institute CEO warns against return to business-as-usual approach

Ruchika Sharma23 April 2022 10:30 AM IST

"The momentum of the past that brought us so far here is lost. As you said it seems for them, it's business as usual," Poonawalla said.

Early trial of Novavax COVID-Influenza vaccine shows promise

Ruchika Sharma23 April 2022 10:00 AM IST

The safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...

Pfizer COVID drug Paxlovid strongly recommended by WHO

Ruchika Sharma22 April 2022 1:32 PM IST

Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old

Ruchika Sharma22 April 2022 1:10 PM IST

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok